Last quarter (Q3 2024), Satellos Bioscience's total revenue was $―, a decrease of ― from the same quarter last year. In Q3, Satellos Bioscience's net income was $-9.05M. See Satellos Bioscience’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20
Total Revenue	$ ―	$ ―	$ ―	$ ―	$ ―
Cost of Revenue	$ ―	$ ―	$ ―	$ 119.92K	$ 48.16K
Gross Profit	$ ―	$ ―	$ ―	$ -119.92K	$ -48.16K
Operating Expense	$ 30.73M	$ 15.46M	$ 8.43M	$ 4.54M	$ 1.43M
Operating Income	$ -30.73M	$ -15.46M	$ -8.43M	$ -4.66M	$ -1.48M
Net Non Operating Interest Income Expense	$ 2.01M	$ 1.16M	$ 20.63K	$ 926.21K	$ 12.61K
Other Income Expense	$ 424.82K	$ 425.00K	$ -45.39K	$ -9.92M	$ -90.71K
Pretax Income	$ -32.10M	$ -15.89M	$ -11.32M	$ -15.51M	$ -1.58M
Tax Provision	$ ―	$ ―	$ 5.62K	$ ―	$ ―
Earnings From Equity Interest Net Of Tax	$ ―	$ ―	$ 42.41K	$ ―	$ ―
Net Income Common Stockholders	$ -28.53M	$ -15.89M	$ -5.07M	$ -15.51M	$ -1.58M
Basic EPS	$ -0.22	$ ―	$ -0.32	$ -0.64	$ -0.05
Diluted EPS	$ -0.22	$ ―	$ -0.32	$ -0.64	$ -0.05
Basic Average Shares	$ 564.09M	$ 86.40M	$ 35.68M	$ 24.08M	$ 32.87M
Diluted Average Shares	$ 564.09M	$ 86.40M	$ 35.68M	$ 24.08M	$ 32.87M
Dividend Per Share	$ ―	$ ―	$ ―	$ ―	$ ―
Total Operating Income As Reported	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Basic E P S	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Diluted E P S	$ ―	$ ―	$ ―	$ ―	$ ―
Rent Expense Supplemental	$ ―	$ ―	$ ―	$ ―	$ ―
Total Expenses	$ 30.73M	$ 15.46M	$ ―	$ -4.66M	$ -1.48M
Net Income From Continuing And Discontinued Operation	$ -28.53M	$ -15.89M	$ -5.07M	$ -15.51M	$ -1.58M
Normalized Income	$ -25.24M	$ -11.68M	$ -5.43M	$ -1.61M	$ -1.16M
Interest Expense	$ ―	$ ―	$ ―	$ ―	$ ―
EBIT	$ -28.53M	$ -15.71M	$ -11.32M	$ -15.51M	$ -1.58M
EBITDA	$ -28.51M	$ -15.71M	$ -10.98M	$ -15.34M	$ -1.58M

Currency in USD

Satellos Bioscience Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing